Cancer gene therapy; Challenges and opportunities

被引：0
|
作者：
Scanlon, KJ [1 ]
机构：
[1] Keck Grad Inst, Claremont, CA 91711 USA
来源：
CANCER GENE THERAPY | 2004年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
S2
引用
收藏
页码：842 / 842
页数：1
相关论文
共 50 条
  • [41] Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy
    Maniam, Geetha
    Mai, Chun-Wai
    Zulkefeli, Mohd
    Dufes, Christine
    Tan, Doryn Meam-Yee
    Fu, Ju-Yen
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [42] Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges
    Wu, Xixi
    Xin, Yuan
    Zhang, Hengtong
    Quan, Liang
    Ao, Qiang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 7415 - 7471
  • [43] Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
    Houman Isazadeh
    Farshid Oruji
    Shima Shabani
    Javad Behroozi
    Hadi Nasiri
    Alireza Isazadeh
    Morteza Akbari
    Molecular Biology Reports, 2023, 50 : 9529 - 9543
  • [44] DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
    Jurkovicova, Dana
    Neophytou, Christiana M.
    Gasparovic, Ana Cipak
    Goncalves, Ana Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [45] CRISPR-Cas9 for cancer therapy: Opportunities and challenges
    Chen, Minjiang
    Mao, Aiwu
    Xu, Min
    Weng, Qiaoyou
    Mao, Jianting
    Ji, Jiansong
    CANCER LETTERS, 2019, 447 : 48 - 55
  • [46] Opportunities and challenges of carbon-based nanomaterials for cancer therapy
    Bianco, Alberto
    Kostarelos, Kostas
    Prato, Maurizio
    EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (03) : 331 - 342
  • [47] Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
    Isazadeh, Houman
    Oruji, Farshid
    Shabani, Shima
    Behroozi, Javad
    Nasiri, Hadi
    Isazadeh, Alireza
    Akbari, Morteza
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (11) : 9529 - 9543
  • [48] Targeting CDK2 in cancer: challenges and opportunities for therapy
    Tadesse, Solomon
    Anshabo, Abel T.
    Portman, Neil
    Lim, Elgene
    Tilley, Wayne
    Caldon, C. Elizabeth
    Wang, Shudong
    DRUG DISCOVERY TODAY, 2020, 25 (02) : 406 - 413
  • [49] Opportunities and challenges for anti-CD73 cancer therapy
    Zhang, Bin
    IMMUNOTHERAPY, 2012, 4 (09) : 861 - 865
  • [50] Genetically modified T cells in cancer therapy: opportunities and challenges
    Sharpe, Michaela
    Mount, Natalie
    DISEASE MODELS & MECHANISMS, 2015, 8 (04) : 337 - 350
12345